Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The liquidation value of the company divide by the number of shares.
"There are still problems in the T3 case on whether TPL has enough evidence to prove past or potential future infringement even if we win big at the Markman Hearings. When the time is right, TPL must hirer more workers. Keep an eye on TPL’s help wanted section to see when they start to hire." Can I ask where this info came from? I would think that TPL would have their ducks in a row on this one. Thanks RJ
.
Share
New Message
Please login to post a reply